Sonoma Pharmaceuticals (SNOA) Other Gross PP&E Adjustments (2017 - 2025)
Sonoma Pharmaceuticals has reported Other Gross PP&E Adjustments over the past 14 years, most recently at -$927000.0 for Q4 2025.
- For Q4 2025, Other Gross PP&E Adjustments fell 134.09% year-over-year to -$927000.0; the TTM value through Dec 2025 reached -$927000.0, down 134.09%, while the annual FY2025 figure was $2.0 million, 13.58% up from the prior year.
- Other Gross PP&E Adjustments for Q4 2025 was -$927000.0 at Sonoma Pharmaceuticals, down from -$556000.0 in the prior quarter.
- Over five years, Other Gross PP&E Adjustments peaked at $2.0 million in Q1 2025 and troughed at -$955000.0 in Q2 2021.
- A 5-year average of -$85200.0 and a median of -$426500.0 in 2023 define the central range for Other Gross PP&E Adjustments.
- Biggest five-year swings in Other Gross PP&E Adjustments: crashed 143.62% in 2021 and later skyrocketed 50.0% in 2023.
- Year by year, Other Gross PP&E Adjustments stood at -$897000.0 in 2021, then soared by 38.35% to -$553000.0 in 2022, then soared by 31.1% to -$381000.0 in 2023, then dropped by 3.94% to -$396000.0 in 2024, then crashed by 134.09% to -$927000.0 in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for SNOA at -$927000.0 in Q4 2025, -$556000.0 in Q3 2025, and -$675000.0 in Q2 2025.